As global regulatory frameworks intensify their focus on excipient safety and ingredient transparency, pharmaceutical and nutraceutical manufacturers are being compelled to reassess formulation strategies at a fundamental level. Enrobage India Pvt. Ltd. is addressing this shift through advanced pharmaceutical coating solutions engineered to align with emerging compliance expectations while maintaining manufacturing efficiency and product integrity.
Established in 2020, the company operates from a WHO-GMP compliant facility in Kala Amb, Himachal Pradesh, supported by its head office in Okhla. Its operational model is built around controlled manufacturing systems, formulation precision, and the ability to respond to increasingly complex regulatory and application-driven requirements across pharmaceutical and nutraceutical coating applications.
Engineering Titanium Dioxide-Free and Talc-Free Coating Systems
The industry-wide transition away from titanium dioxide and talc is not merely a reformulation exercise, but a technical challenge involving stability, opacity, process adaptability, and visual uniformity. Enrobage’s clean-label coating systems are developed to address these variables through carefully engineered compositions that deliver equivalent, or improved performance without reliance on restricted excipients.
These pharmaceutical coating systems are designed to integrate into existing manufacturing environments with minimal process disruption, ensuring that excipient compliance transitions do not introduce variability in coating behaviour, finish quality, or throughput efficiency.
Bagecoat: A Structured Coating Platform Across Functional Applications
At the core of Enrobage’s offering is Bagecoat, positioned not simply as a product range but as a structured coating platform addressing multiple functional and process requirements. The platform spans immediate-release film coating systems, enteric coatings for site-specific drug delivery, and sustained or modified release coatings designed to control release kinetics.
In addition, the platform incorporates moisture barrier coatings, advanced taste-masking technologies, and precision colour coating systems enabled by computerised colour matching infrastructure. This ensures reproducibility and batch-to-batch consistency, critical parameters in regulated pharmaceutical manufacturing where even minor deviations can impact product acceptance.
 The platform is further engineered to enable coating weight gain optimisation, improving coating process efficiency without compromising film integrity. It also incorporates targeted strategies to minimise coating defects such as picking, peeling, and logo bridging, thereby enhancing surface quality, dosage form aesthetics, and overall manufacturing yield.
Advancing Coating Solutions for Nutraceutical and Softgel Applications
Nutraceutical and softgel coating segments are witnessing accelerated growth, accompanied by increased scrutiny around label transparency and formulation simplicity. Enrobage’s nutraceutical coating solutions are specifically adapted to these segments, balancing functional performance with evolving clean-label expectations.
This includes coating systems that maintain aesthetic appeal and stability while supporting simplified ingredient profiles, enabling manufacturers to align with both regulatory direction and consumer-driven demand without compromising formulation robustness or product performance.
Manufacturing Systems Designed for Consistency and Global Compliance
Enrobage’s manufacturing infrastructure is designed to support high levels of process control and quality assurance. The facility operates in compliance with WHO-GMP standards and is supported by certifications including ISO 9001:2015, Halal, and FSSAI. The company is also progressing toward globally recognised certifications such as EXCiPACT, USDMF, Kosher, HACCP, and Swiss Quality.
 This is reinforced by dedicated formulation R&D capabilities and structured, continuous coating performance improvement programs, enabling ongoing optimisation of coating behaviour, process reproducibility, and application-specific performance in line with evolving regulatory and market requirements.
This layered certification approach reflects a clear intent to meet diverse regulatory expectations across international markets while ensuring consistency in product quality and supply reliability.
Technical Collaboration as a Core Capability
A distinguishing aspect of Enrobage’s approach lies in its formulation-centric engagement with clients. Rather than offering standardised solutions, the company works closely with formulation scientists and production teams to develop customised pharmaceutical coating solutions aligned with specific product requirements and process conditions.
This includes optimisation of coating parameters, adaptation to equipment configurations, and addressing formulation-specific challenges such as hygroscopicity, taste masking, and release modulation—critical factors in achieving robust and scalable coating performance.
Strengthening Global Presence Through Industry Platforms
Enrobage continues to expand its global engagement through participation in key industry platforms including CPHI Worldwide, CPHI India, CPHI Japan, and IPHEX. These platforms serve as critical interfaces for technical exchange, market insight, and collaboration with stakeholders across the global pharmaceutical and nutraceutical manufacturing value chain.
Enrobage India: Enabling the Transition to Next-Generation Coating Technologies
Enrobage India Pvt. Ltd. is positioning itself at the forefront of pharmaceutical coating technology evolution by combining formulation expertise, regulatory foresight, and application-driven development. Its focus extends beyond product supply to enabling manufacturers to navigate ongoing shifts in excipient compliance, performance expectations, and global market dynamics.
Through its clean-label coating systems and structured platform approach, the company is contributing to the next phase of pharmaceutical and nutraceutical manufacturing, where technical precision, regulatory alignment, and formulation transparency are no longer optional, but essential.
